The goal of Dr. Miller’s research is to determine how mutations in blood cells give rise to pre-malignant blood conditions such as clonal hematopoiesis (CH), which drive the development of blood cancers. To this end, Dr. Miller will study patients with rare inherited diseases and use experimental models in the laboratory. He ultimately seeks to use the data generated through this research to develop new strategies to predict, prevent, and treat highly lethal blood cancers.
Damon Runyon Researchers
Meet Our Scientists
Peter G. Miller, MD, PhD
Project title: The role of RecQ helicases in premalignant hematopoiesis and myeloid neoplasia
Institution: Massachusetts General Hospital
Award Program: Clinical Investigator
Sponsor(s) / Mentor(s): Timothy A. Graubert, MD & David T. Scadden, MD
Cancer Type: Other Cancer
Research Area: Carcinogenesis
